Atlas Trials

Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.

Clinical trial NCT06205472 · RECRUITING

Trial details

NCT number
NCT06205472
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular CarcinomaNarrow MarginRadiotherapy
Start date
2024-01-26
Primary completion
2025-12-12
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.